Metviron Trio 2mg Tablet
Metviron Trio 2mg Tablet
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)
Cheaper alternative availability
Already at the Best Price
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
About This Medicine
Product description & overview
Metviron Trio 2mg Tablet is a combination medication containing glimepiride, metformin, and voglibose, used to treat type 2 diabetes mellitus. The tablet combines the sulfonylurea glimepiride, which stimulates insulin secretion, with the biguanide metformin, which reduces glucose production in the liver and increases glucose uptake in the muscles. Voglibose, a alpha-glucosidase inhibitor, slows down the digestion of carbohydrates in the small intestine, thereby reducing the postprandial glucose excursion. The combination of these three agents in Metviron Trio 2mg Tablet provides a comprehensive approach to glucose control, helping to regulate blood sugar levels and improve patient outcomes. As a once-daily tablet, Metviron Trio 2mg Tablet offers a convenient dosing regimen for patients with type 2 diabetes, simplifying their treatment and improving adherence to their medication.
Active composition
Metformin 500 mg
+2 more active ingredients
About Metformin
Metformin is an oral antihyperglycemic agent used to manage type 2 diabetes mellitus. It works by decreasing glucose production in the liver and improving insulin sensitivity. Metformin is effective in controlling blood sugar levels and preventing diabetes-related complications. In summary, Metformin is vital for managing type 2 diabetes.
How It Works
Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.
All Active Ingredients
Glimepiride
Glimepiride stimulates insulin secretion from pancreatic beta cells and enhances insulin sensitivity in peripheral tissues, facilitating glucose uptake and lowering blood sugar levels.
Voglibose
Voglibose inhibits intestinal alpha-glucosidases, delaying carbohydrate digestion and absorption, thus lowering postprandial glucose levels.
Dosage & How to Use
Dosage information not available. Please consult your doctor or pharmacist.
Safety Advice
Important precautions
Side Effect Occurrence
Based on clinical trials and patient reports.
Overall Tolerance
Most patients tolerate well
Common Side Effects
Safety Advice
Alcohol
It is unsafe to consume alcohol with Metviron Trio 2mg Tablet.
High Risk
Pregnancy
Metviron Trio 2mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Medical Advice
Driving
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Exercise Caution
Liver
Metviron Trio 2mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Metviron Trio 2mg Tablet may be needed. Please consult your doctor. Metviron Trio 2mg Tablet is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.
Regular Checkup
Breastfeeding
Metviron Trio 2mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Consult Doctor
Kidney
Metviron Trio 2mg Tablet is probably unsafe to use in patients with kidney disease and should be avoided. Please consult your doctor. Use of Metviron Trio 2mg Tablet is, however, not recommended in patients with severe kidney disease.
Regular Checkup
Customer Reviews
0 reviews for Metviron Trio 2mg Tablet
